EXPLAINED: Do wall street analysts like abbott laboratories stock - The Real Truth

With a market cap of $189.6 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells a wide range of medical products across pharmaceuticals, diagnostics, nutrition, and medical devices. It serves patients worldwide with solutions spanning disease treatment, testing and diagnostics, nutrition, cardiovascular care, diabetes management, and neuromodulation.

Shares of the Abbott Park, Illinois-based company have underperformed the broader market over the past 52 weeks. ABT stock has decreased 15.1% over this time frame, while the broader S&P 500 Index ($SPX) has gained 15.4%. Moreover, the stock has declined nearly 13% on a YTD basis, compared to SPX's 1.1% rise.